They further confirmed that miR-29a-3p, under the positive regulation of XPD, targets Mdm2 (a negative regulator of P53) and the PDGF-B axis, inhibiting the progression of HCC. This evidence concerns the gene ERCC2 and hepatocellular carcinoma.